Can Alternative Payment Models And Value-Based Insurance Design Alter The Course Of Diabetes In The United States?

Health Aff (Millwood). 2022 Jul;41(7):980-984. doi: 10.1377/hlthaff.2022.00235. Epub 2022 Jun 27.

Abstract

Diabetes process and outcome measures are common quality measures in payment reform models, including Alternative Payment Models (APMs) and value-based insurance design (VBID). In this commentary we review evidence from selected research to examine whether these payment models can improve the value of diabetes care. We found that higher-risk APMs yielded greater improvements in diabetes process measures than lower-risk APMs, and that VBID models appeared to improve medication adherence but not other quality measures. We argue that these models are promising first steps in redesigning the payment system to improve diabetes care. However, greater coordination and alignment across models is needed to enhance their impact on providers' behavior, diabetes care processes, and patient health outcomes.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Diabetes Mellitus* / therapy
  • Humans
  • United States
  • Value-Based Health Insurance*